{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:42:32Z","timestamp":1789195352624,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ijantimicag.2011.11.016","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T23:37:41Z","timestamp":1328312261000},"page":"321-325","source":"Crossref","is-referenced-by-count":11,"title":["Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia"],"prefix":"10.1016","volume":"39","author":[{"given":"Douglas J.","family":"Biedenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Liverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/11585430-000000000-00000","article-title":"Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use","volume":"71","author":"Frei","year":"2011","journal-title":"Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.11.016_bib0010","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0015","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1586\/eri.10.110","article-title":"Fluoroquinolones in the management of community-acquired pneumonia in primary care","volume":"8","author":"Wispelwey","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0732-8893(03)00087-7","article-title":"Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Gordon","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3810\/pgm.2008.09.suppl52.280","article-title":"Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective","volume":"120","author":"Sahm","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2010.04.013","article-title":"Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia","volume":"36","author":"Jones","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2011.11.016_bib0040","first-page":"iv3","article-title":"The problem of complicated skin and skin structure infections: the need for new agents","volume":"65","author":"Moellering","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diagmicrobio.2004.12.009","article-title":"Therapeutic options among broad-spectrum \u03b2-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae","volume":"52","author":"Jones","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0050","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/163.6.1279","article-title":"Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus","volume":"163","author":"Blumberg","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2010.09.018","article-title":"Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox\u00ae Annual Appraisal of Potency and Spectrum program","volume":"68","author":"Biedenbach","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijmm.2010.05.004","article-title":"Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage","volume":"301","author":"Pletz","year":"2011","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2009.02.002","article-title":"Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997\u20132006","volume":"34","author":"Adam","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0732-8893(03)00016-6","article-title":"Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program","volume":"46","author":"Biedenbach","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0732-8893(98)00083-2","article-title":"Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)","volume":"32","author":"DiPersio","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/JCM.01561-07","article-title":"Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children","volume":"46","author":"Yokota","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0085","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1128\/AAC.00294-08","article-title":"Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates","volume":"52","author":"Jones","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0090","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.01374-09","article-title":"In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone","volume":"54","author":"Morrow","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0095","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/AAC.01407-05","article-title":"In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2011.11.016_bib0100","first-page":"S249","article-title":"Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia","volume":"47","author":"Spellberg","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0105","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1128\/AAC.00162-11","article-title":"JNJ-Q2: a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains","volume":"55","author":"Farrell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0110","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed.. Document M07-A8. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000253059.84602.c3","article-title":"Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States","volume":"26","author":"Farrell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0120","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011."},{"key":"10.1016\/j.ijantimicag.2011.11.016_bib0125","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, January 2011. EUCAST; 2011. http:\/\/www.eucast.org\/clinical_breakpoints\/ [accessed 5 January 2012]."},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2011.11.016_bib0130","first-page":"iii3","article-title":"Changing needs of community-acquired pneumonia","volume":"66","author":"Ramirez","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T10:52:32Z","timestamp":1543229552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0924857912000052"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.11.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}